Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02572167
Title A Study of Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Seattle Genetics, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope National Medical Center Duarte California 91010-3000 United States Details
Stanford Cancer Center Stanford California 94305 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Karmanos Cancer Institute / Wayne State University Detroit Michigan 48201 United States Details
Mayo Clinic Minnesota Rochester Minnesota 55905 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
University of Nebraska Medical Center Omaha Nebraska 68198-7680 United States Details
Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Memorial Sloan Kettering Cancer Center - Commack Commack New York 11725 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10021 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
James Cancer Hospital / Ohio State University Columbus Ohio 43210 United States Details
Charles A. Sammons Cancer Center / Baylor University Medical Center Dallas Texas 75246 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field